Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 106.62 billion. The enterprise value is 117.33 billion.
Market Cap | 106.62B |
Enterprise Value | 117.33B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | May 12, 2025 |
Share Statistics
Sanofi has 1.22 billion shares outstanding. The number of shares has decreased by -0.31% in one year.
Current Share Class | 1.22B |
Shares Outstanding | 1.22B |
Shares Change (YoY) | -0.31% |
Shares Change (QoQ) | -1.57% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 60.02% |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 17.58 and the forward PE ratio is 10.57. Sanofi's PEG ratio is 0.98.
PE Ratio | 17.58 |
Forward PE | 10.57 |
PS Ratio | 2.36 |
PB Ratio | 1.37 |
P/TBV Ratio | 5.37 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 0.98 |
Enterprise Valuation
EV / Earnings | 18.63 |
EV / Sales | 2.60 |
EV / EBITDA | 9.31 |
EV / EBIT | 12.30 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.44 |
Debt / FCF | n/a |
Interest Coverage | 17.14 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 6.23% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 544,970 |
Profits Per Employee | 76,003 |
Employee Count | 82,878 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.22% in the last 52 weeks. The beta is 0.43, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.43 |
52-Week Price Change | -0.22% |
50-Day Moving Average | 94.85 |
200-Day Moving Average | 98.29 |
Relative Strength Index (RSI) | 33.59 |
Average Volume (20 Days) | 2,266,306 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 45.17 billion and earned 6.30 billion in profits. Earnings per share was 5.04.
Revenue | 45.17B |
Gross Profit | 32.05B |
Operating Income | 9.39B |
Pretax Income | 7.87B |
Net Income | 6.30B |
EBITDA | 12.15B |
EBIT | 9.39B |
Earnings Per Share (EPS) | 5.04 |
Balance Sheet
The company has 7.56 billion in cash and 17.91 billion in debt, giving a net cash position of -10.36 billion or -8.50 per share.
Cash & Cash Equivalents | 7.56B |
Total Debt | 17.91B |
Net Cash | -10.36B |
Net Cash Per Share | -8.50 |
Equity (Book Value) | 77.86B |
Book Value Per Share | 61.83 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 70.96%, with operating and profit margins of 20.80% and 13.95%.
Gross Margin | 70.96% |
Operating Margin | 20.80% |
Pretax Margin | 17.41% |
Profit Margin | 13.95% |
EBITDA Margin | 26.90% |
EBIT Margin | 20.80% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 4.26%.
Dividend Per Share | 3.92 |
Dividend Yield | 4.26% |
Dividend Growth (YoY) | 4.26% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 0.31% |
Shareholder Yield | 4.57% |
Earnings Yield | 5.91% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |